Wakamoto Pharmaceutical: Confirmation letter
Wakamoto Pharmaceutical: Half Year Report - Term 130 (2024/04/01 - 2025/03/31)
Wakamoto Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)
Wakamoto Pharmaceutical: FY2025 Q1 financial statement (Japan standard, non-consolidated)
Wakamoto Pharmaceutical: Extraordinary Report
Wakamoto Pharmaceutical: Confirmatory letter.
Wakamoto Pharmaceutical: Securities Report - 129th Fiscal Year (April 1, 2023 - March 31, 2024)
Wakamoto Pharmaceutical: (Correction/Numerical data correction) Partial correction of the 'March 2024 financial results briefing (Japan standard) (Non-consolidated)'.
WAKAMOTO PHARMACEUTICAL: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
WAKAMOTO PHARMACEUTICAL: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical: Notice regarding revisions to dividend forecasts
Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical: Quarterly Report - 129th Term 3rd Quarter (2023/10/01 - 2023/12/31)
Wakamoto Pharmaceutical: Confirmation
Wakamoto Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical: Confirmation letter
Wakamoto Pharmaceutical: Quarterly Report - Period 129th Second Quarter (2023/07/01 - 2023/09/30)
Wakamoto Pharmaceutical: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)
Wakamoto Pharmaceutical: Confirmation letter
No Data
No Data